For South San Francisco, California residents, geographic distance from mainland pharmacies has historically affected access to specialty medications. Ozempic® is the FDA-approved Injectable pen Semaglutide product manufactured by Novo Nordisk; Pacific-region retail pricing varies by pharmacy. Weight Method offers a separate telehealth program: licensed California providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program is priced at $199/month uniformly, shipped directly to your South San Francisco address.
FDA-approved Ozempic prescribed by licensed providers. Delivered to your door.
Free consultation · No commitment · Results in weeks
From 2,000+ patients · South San Francisco is already seeing results
Ozempic in South San Francisco, CA: an FDA-approved GLP-1 medication shown to achieve 15-22% body weight loss in clinical trials. Weight Method offers Ozempic to patients in South San Francisco from $199/month with virtual consultations and direct-to-door shipping.
Ozempic® by Novo Nordisk is the FDA-approved Injectable pen Semaglutide product, taken Once weekly and approved in 2017 for Type 2 diabetes. Semaglutide works by mimicking incretin hormones that regulate hunger and satiety, reducing appetite and helping you feel full with smaller portions. Weight Method is a separate telehealth program for South San Francisco residents: licensed providers evaluate eligible patients and prescribe compounded Semaglutide, dispensed by a U.S.-licensed 503A pharmacy. Compounded Semaglutide is not FDA-approved. The Weight Method program starts at $199/month and includes the provider evaluation, the medication, ongoing care, and home delivery.
Hispanic adults in South San Francisco face disproportionately high rates of obesity and type 2 diabetes — conditions that Semaglutide therapy is studied for. Weight Method removes barriers that have historically limited access: our platform is fully bilingual, and our compounded Semaglutide program (dispensed by a U.S.-licensed 503A pharmacy; compounded Semaglutide is not FDA-approved) starts at $199/month with no insurance needed. Everything happens virtually from your South San Francisco home.
Compounded GLP-1 medications dispensed by U.S.-licensed 503A pharmacies.

Compounded semaglutide. Once-weekly subcutaneous injection.

Compounded tirzepatide. Dual-action GLP-1/GIP, once-weekly subcutaneous injection.
Consult with a licensed provider in California and start Ozempic from $199/month.
Get Started NowFree consultation. No commitment.